Cargando…
Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD
Pulmonary hypertension (PH) due to chronic obstructive pulmonary disease (COPD) is classified as Group 3 PH, with no current proven targeted therapies. Studies suggest that cigarette smoke, the most risk factor for COPD can cause vascular remodelling and eventually PH as a result of dysfunction and...
Autores principales: | Alqarni, Abdullah A., Aldhahir, Abdulelah M., Alghamdi, Sara A., Alqahtani, Jaber S., Siraj, Rayan A., Alwafi, Hassan, AlGarni, Abdulkareem A., Majrshi, Mansour S., Alshehri, Saad M., Pang, Linhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597708/ https://www.ncbi.nlm.nih.gov/pubmed/37881627 http://dx.doi.org/10.3389/fmed.2023.1275684 |
Ejemplares similares
-
Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review
por: Alqarni, Abdullah A., et al.
Publicado: (2023) -
Physicians’ Attitudes, Beliefs and Barriers to a Pulmonary Rehabilitation for COPD Patients in Saudi Arabia: A Cross-Sectional Study
por: Aldhahir, Abdulelah M., et al.
Publicado: (2022) -
Physicians’ Perceptions of and Barriers to Cardiopulmonary Rehabilitation for Heart Failure Patients in Saudi Arabia: A Cross-Sectional Study
por: Aldhahir, Abdulelah M., et al.
Publicado: (2022) -
Attitudes, confidence, barriers and current practice of managing depression in patients with COPD in Saudi Arabia: a national cross-sectional survey
por: Siraj, Rayan A, et al.
Publicado: (2023) -
Prevalence of Nomophobia and Its Impact on Academic Performance Among Respiratory Therapy Students in Saudi Arabia
por: Aldhahir, Abdulelah M, et al.
Publicado: (2023)